Healthcare and Life Science
Owlstone Medical announces $27 Million USD first close in Series E financing round
Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of Breath Biopsy diagnostic tests and point of care devices for lung cancer, li...
Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification
Scalable Weak Anion Exchange and Hydrophobic Interaction (AEX-HIC) Mixed-Mode Chromatography Resin Enables Small- to Large-Scale Purification for Research and Biotherapeutic Applications ...
Sapio Sciences announces enhanced capabilities for chemistry, immunogenicity, GMP and molecular biology
Sapio Lab Informatics Platform (Release 24.12) further optimizes productivity across lab workflows ...
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers
Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers ...
Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development
Solutions driven by proprietary, integrated multi-omics platform to support data-driven, faster and more precise drug discovery and development, to be introduced during JPM Week Provides customers with access to Enhanced’s 3D genomics technology and 3D Multi-Omic Platform, to trans...
Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802
UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosisEdinburgh, UK, 14 January 2025: Pheno Therapeutics Limited., a biotechnology company focused on the disco...
CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan
Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise Partnership solidifies CN Bio’s presence in Asian markets and supports ongoing global expansionCambridge, UK, 14 January 2025: CN Bio, a leading provider of Organ-on-a-ch...
Sable&Hawkes appointed for major new environment design project with Gt Ormond Street Hospital
Great Ormond Street Hospital (GOSH) is a world-renowned international centre of excellence in child healthcare. Cambridge-based design and communication agency Sable&Hawkes was commissioned by GOSH to work with them on a major new environment and signage project. ...
Guardtech’s ‘full life cycle’ approach offering cleanroom facility protection from start to finish
Suffolk-based contamination control specialists’ holistic cleanroom installation programmes boast comprehensive maintenance and decontamination aftercare packages. ...
4basebio appoints Gabe Longoria as Chief Commercial Officer
Cambridge, UK, 09 January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced the appointment of Gabe Longoria as Chief Commercial Officer o...